Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...
The agency is also evaluating Novo Nordisk’s (NVO) semaglutide drugs for the ... clinics have been deemed risky since they ...
Compounded semaglutide: Medication produced by compounded pharmacies instead of the original drug manufacturer (Novo Nordisk, ...
Other pharmaceutical players such as Roche, Amgen, Pfizer, AstraZeneca and Boehringer also have obesity drugs in the pipeline ...
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
The South African on MSN3d
Warnings over buying fake versions of OzempicThe SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...
Novo Nordisk has announced plans to move its ziltivekimab ... with options including cholesterol-lowering drugs and extra medications for fluid retention or heart failure. Data were announced ...
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...
Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback